Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger M Pinder

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Neuropsychiatric Disease and Treatment|June 24, 2008
Why a new journal in the crowded area of neuroscience?Roger M Pinder
Human Psychopharmacology|October 31, 2002
On the feasibility of designing new antidepressantsRoger M Pinder
Acta Neuropsychiatrica|March 18, 2016
Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?Roger M Pinder
Neuropsychiatric Disease and Treatment|August 30, 2008
Drugs for Parkinson’s disease: levodopa is still the gold standardRoger M Pinder
Neuropsychiatric Disease and Treatment|March 21, 2009
NDT goes Open AccessRoger M Pinder, Allan Young
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 11, 2003
Chairmen's introductionSteven P Roose, Roger M Pinder
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2002
Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressantsMartin M Katz, Uriel M Halbreich, Charles L Bowden, et al.
The Journal of Clinical Psychiatry|August 29, 2002
Selecting methodologies for the evaluation of differences in time to response between antidepressantsStuart A Montgomery, Per Bech, Pierre Blier, et al.
The International Journal of Neuropsychopharmacology|March 8, 2008
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidenceNorman Sartorius, Thomas C Baghai, David S Baldwin, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Neuropsychiatric Disease and Treatment|June 24, 2008
Why a new journal in the crowded area of neuroscience?Roger M Pinder
Human Psychopharmacology|October 31, 2002
On the feasibility of designing new antidepressantsRoger M Pinder
Acta Neuropsychiatrica|March 18, 2016
Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?Roger M Pinder
Neuropsychiatric Disease and Treatment|August 30, 2008
Drugs for Parkinson’s disease: levodopa is still the gold standardRoger M Pinder
Neuropsychiatric Disease and Treatment|March 21, 2009
NDT goes Open AccessRoger M Pinder, Allan Young
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 11, 2003
Chairmen's introductionSteven P Roose, Roger M Pinder
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2002
Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressantsMartin M Katz, Uriel M Halbreich, Charles L Bowden, et al.
The Journal of Clinical Psychiatry|August 29, 2002
Selecting methodologies for the evaluation of differences in time to response between antidepressantsStuart A Montgomery, Per Bech, Pierre Blier, et al.
The International Journal of Neuropsychopharmacology|March 8, 2008
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidenceNorman Sartorius, Thomas C Baghai, David S Baldwin, et al.
Pageof 2